Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy

BACKGROUND. In the U.S., neoadjuvant chemotherapy (NAC) for nonmetastatic breast cancer (BC) is used with extensive disease and aggressive molecular subtypes. Little is known about the influence of demographic characteristics, clinical factors, and resource constraints on NAC use in Africa. MATERIAL...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncologist
Autors principals: O'Neil, Daniel S., Nietz, Sarah, Buccimazza, Ines, Singh, Urishka, Čačala, Sharon, Stopforth, Laura W., Joffe, Maureen, Jacobson, Judith S., Neugut, Alfred I., Crew, Katherine D., Ruff, Paul, Cubasch, Herbert
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2018
Matèries:
Global Health and Cancer
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656461/
https://ncbi.nlm.nih.gov/pubmed/30518615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0535
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars